Executive Directors and Advisory Board

Mr. Awni Ayoubi

With over 25 years of engineering, management, and product and business development, Awni is Rostrum’s President, CEO, Co-founder and Co-developer. He was the Principal Co-founder and Co-developer of Saturn Biomedical and the GlideScope® Video Laryngoscope (Acquired by Verathon in January 2006) and other successful ventures. Assoc. P. Eng. of BC and Ontario.

William Stewart

Mr. William Stewart

Rostrum’s Director and Business Advisor with extensive experience that spans market development and commercialization in the anesthesia and pharmaceutical markets. Will is the former CEO and owner of Vitaid Ltd. until the acquisition by the LMA Company Ltd./Teleflex in Oct.2012. He has contributed to the successful commercialization and distribution in Canada and the US for the GlideScope® Video Laryngoscope, and other medical devices in the anesthesiology and emergency medicine markets.

Dr. Georg Brady

Rostrum’s Director and Business Advisor, Dr. Brady, is CEO of C. Brady GesMBH & Co KG in Vienna, Austria. He completed medical studies at Vienna University and qualified for government licenses. Since 1995, he has been managing the pharmaceutical and medical devices divisions of the company.

Georg Brady
Daguang Wang

Mr. Daguang Wang

Managing Director at Yonjin Capital; Ph.D. in Molecular Genetics, Wash. Univ. (St. Louis)
Over twenty years’ experience in biotech and pharma research and development/business development. Formerly a global lead of business development/external innovation of Sanofi Neuroscience. Board member/board observer of multiple Yonjin/Yonghua North America portfolio companies.

Mr. Scott Phillips

Mr. Phillips, Founder and CEO of StarFish Medical brings to the Rostrum Medical Board of Directors over 30 years of experience in the medical device industry. He holds a degree in Engineering Physics from the University of British Columbia. Under his leadership, StarFish has grown into a diverse professional organization with clients around the world and 100% focus on medical devices. He is a Chair of the LifeSciences British Collumbia board, Fellow of The Canadian Academy of Engineering, winner of the EY Entrepreneur of The Year 2017 Pacific Awards Technology category, 2017 recipient of the VIATEC Technology champion award, and others.

Scientific and Medical Advisory Board

Dr. (Prof) Richard Cooper


Professor Emeritus, Department of Anesthesia, University of Toronto.

Dr. Richard Cooper
Dr. Bernard Cholley

Dr. (Prof) Bernard Cholley


Service d’Anesthésie-Réanimation, Hôpital Européen Georges Pompidou Paris.

Dr. (Prof) Neal Fleming


Department of Anesthesiology and Pain Medicine UC Davis School of Medicine, Sacramento, California

Dr. Neal Fleming
Michael Hiesmayr

Dr. (Prof) Michael Hiesmayr


Professor and Head; Division of Cardiac – Thoracic – Vascular Anesthesia and Intensive Care. Anesthesia, Allgemeines Krankenhaus der Stadt Wien (AKH), Vienna, Austria

Dr. Matteo Parotto, MD, PhD

Dr. Matteo Parotto, MD, PhD – Staff anesthesiologist at Toronto General Hospital, clinical fellowships in critical care medicine, cardiovascular anesthesia and cardiac intensive care. His understanding of physiology and cardiorespiratory pathology will be a real asset during Rostrum’s next phase of activity.

Management Team

Nathan Ayoubi – Vice President

Nathan completed his studies at the University of British Columbia with a B.Sc. and the University of Victoria in Project Management. He is the co-developer of the VQm® group of products and has been with Rostrum since its inception in 2009. Nathan is closely involved with the Medical Advisory Board and clinicians globally and focuses on the clinical validation efforts with Rostrum’s Clinical Specialists. He guides the Technical, Clinical, Regulatory Affairs, and Quality Assurance and Commercial managers in achieving company objectives.

James Garry, PhD – Director, Design and Development

James directs the development of novel devices and processes for Rostrum Medical. He has a background in Applied Aerospace Sciences and was instrumental in the design and calibration of sensors on a handful of planetary spacecraft for NASA and ESA. He is a member of two ASTM committees and has held the title of ‘Chartered Physicist’ since 2008.

Priyaka Rangana – Sr. Manager, SW

Priyaka has over 10 years of experience in developing medical devices, supplemented by over 20 years in the software industry. He completed his B.Sc at the University of Colombo. As a certified scrum master, he orchestrated rapid innovation and development to expedite software development within the team. His prior experiences include working on PACS systems and GPS devices.

Proinnsías Mc Gleenan – Project Manager

Proinnsías oversees the design, development, testing and manufacturing of devices for Rostrum Medical from a systems and project management viewpoint. His background lies in the medical diagnostics industry where he coordinated the electrical/electronic design of molecular & immunoassay diagnostic analyzers. He holds an Master of Engineering (MEng) in Electrical and Electronic Engineering from Queen’s University Belfast.

Steven Poon, PhD – Principal Engineer, SW

Steven has over 30 years in the life science industry with experience in managing and developing automation products and applications in biotechnology from concept to commercialization. He has a proven ability in innovation, fostering interdepartmental collaboration, and delivering success. Steven holds a Ph.D. in Electrical Engineering from the University of British Columbia and has created numerous machine vision applications.

Hanna McGregor, PhD – Clinical Researcher

Hanna analyzes the medical applications of Rostrum’s products, liaises with the Medical Advisory Board to determine Rostrum’s overall clinical direction, and oversees the development and evaluation of product clinical testing. Her background includes interdisciplinary lung disease research, clinical applications of novel technologies, and design of research studies for new medical devices. Hanna received her Ph.D. from the University of British Columbia by conducting pilot studies and clinical trials utilizing spectroscopic technologies to aid in the detection of early lung cancers.